Provention Bio, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2020 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Provention Bio, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2020 to Q1 2022.
  • Provention Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $2.15M, a 97.9% decline year-over-year.
  • Provention Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $129M, a 26.4% increase from 2021.
  • Provention Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $102M, a 10.4% decline from 2020.
  • Provention Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $114M, a 81.6% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $2.15M -$100M -97.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q1 2021 $102M +$102M +52672% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $194K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.